Guidelines for estimating the economic burden of diarrhoeal disease, with focus on assessing the costs of rotavirus diarrhoea

Guidelines for estimating the economic burden of diarrhoeal disease, with focus on assessing the costs of rotavirus diarrhoea
  • WHO Team
    Vaccine Assessment and Monitoring Team of the Department of Immunization, Vaccines and Biologicals
  • Update
    10.09.2024
  • Reference
    WHO/IVB/05.10
  • Copyright
    --

The objective of these guidelines is to present a method for determining the costs associated with diarrhoeal disease in children under five years of age. Methods for estimating the costs from the viewpoint of the health sector and for society as a whole are explained. Costs associated with diarrhoea include direct medical costs (medication, diagnostics, personnel and hospital bed-day costs) borne by providers, patients and caregivers, non-medical direct costs (e.g. travel costs) borne by patients/caregivers, and costs of time lost from productive work (indirect costs) borne by patients/caregivers and/or society. These guidelines provide recommendations on how to estimate all these types of costs. An estimate of the overall economic burden of diarrhoeal disease can be used for three major purposes and types of analysis: raising awareness, planning and budgeting, and cost-effectiveness analysis of interventions for the control of diarrhoea. The guidelines are targeted at health economists, public health planners and epidemiologists. In particular, researchers involved in hospital or community-based surveillance of diarrhoeal disease could use the guidelines to add an economic burden component to their study.

This tool provides guidance on the following steps of the policy/action cycle

Identify high- priority issue

Direct download Get notified when this document is updated
Document type
Languages